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Multiplexed, phenotypic, intravital cytometric imaging requires
novel fluorophore conjugates that have an appropriate size for
long circulation and diffusion and show virtually no nonspecific
binding to cells/serum while binding to cells of interest with high
specificity. In addition, these conjugates must be stable and
maintain a high quantum yield in the in vivo environments. Here,
we show that this can be achieved using compact (∼15 nm in
hydrodynamic diameter) and biocompatible quantum dot (QD) -Ab
conjugates. We developed these conjugates by coupling whole
mAbs to QDs coated with norbornene-displaying polyimidazole
ligands using tetrazine–norbornene cycloaddition. Our QD immu-
noconstructs were used for in vivo single-cell labeling in bone
marrow. The intravital imaging studies using a chronic calvarial
bone window showed that our QD-Ab conjugates diffuse into
the entire bone marrow and efficiently label single cells belonging
to rare populations of hematopoietic stem and progenitor cells
(Sca1+c-Kit+ cells). This in vivo cytometric technique may be useful
in a wide range of structural and functional imaging to study the
interactions between cells and between a cell and its environment
in intact and diseased tissues.
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Studying migration of individual endogenous cells and theirinteractions with the surrounding microenvironment in vivo
would greatly help expand our knowledge on how cells behave in
their complex native biological network. However, single-cell
imaging of a rare population in vivo places highly stringent
constraints on targeting fluorophores. First, identifying specific
cell populations among various types of cells expressing over-
lapping surface markers demands simultaneous labeling of
multiple markers, and therefore requires fluorophores with
narrow emission features. Second, the size of targeting fluorophore
conjugates needs to be optimized to simultaneously achieve both
long blood circulation times and high diffusion in dense in vivo
environments. Third, because only a small fraction of systemically
administered fluorophores is delivered to the targeting sites,
resulting in low signal, targeting fluorophore conjugates must emit
bright signals and exhibit minimal nonspecific binding to serum
proteins and cells. Fourth, targeting fluorophore conjugate samples
must be free of unbound targeting molecules, because unbound
targeting molecules can block target sites and yield decreased signal.
Because of the lack of such a technology, direct labeling of
single cells from an endogenous rare cell population in live
and nonmanipulated animal models has not been possible. Instead,
researchers have used (i) immunohistochemistry (1), (ii) ex vivo (2)
or intravital imaging (3) of injected target cells, which are fluo-
rescently labeled ex vivo, or (iii) ex vivo (4) or intravital imaging (5,
6) of target cells that are genetically modified to express fluorescent
markers. However, none of these methods reproduce the native
microenvironment of target cells. Tissue immunohistochemistry and
ex vivo imaging only provide a snapshot image of a perturbed state.
Intravital imaging allows for real-time imaging but requires either
genetically engineered mouse models to induce endogenous ex-
pression of fluorescence proteins in cells or irradiation of mice for
marrow depletion and repopulation with systemically infused cells.
Quantum dots (QDs) possess unique optical properties that
are ideal for in vivo imaging in live animals. Specifically, QDs
have a tunable band gap ranging from the visible to the IR, high
quantum yields (QYs), narrow and symmetric emission features,
broad absorption above the band gap, large multiphoton ab-
sorption cross-sections, and high photostability (7–10). These
properties make QDs amenable to optical multiplexing for si-
multaneous study of various targets, long-term tracking, and
deep-tissue imaging using multiphoton microscopy. Despite
these exciting capabilities, most imaging studies using QDs have
involved either in vitro targeting or ensemble measurements of
QD signals over large volumes of tissue in vivo (11–15). This
restriction is caused by a lack of technology for synthesizing QD
conjugates that are optimal for single-cell imaging in vivo.
Here, we report the development of QD-Ab conjugates that
satisfy all of the constraints described above. Moreover, we used
these QD-Ab conjugates for in vivo cytometry of endogenous
bone marrow cells (BMCs) in their unperturbed microenviron-
ment. Our technique provides opportunities to study the move-
ments of single cells and the interactions between cells and
between a cell and its environment in their native states.
Synthesis and Characterization of QD-norbornene–
tetrazine-Ab
We previously developed polyimidazole ligands (PILs) incorporating
norbornene (NBPILs) for QDs (16). PILs (random copolymers
Significance
One of the key questions in biology is understanding how cells
move, interact, and evolve in living organisms. Tremendous
efforts have been made to answer these questions in vitro,
which have yielded a molecular-level understanding of cellular
events. However, an increasing number of studies indicate that
cellular activities need to be understood in the context of their
natural environments. Single-cell labeling methods in use cur-
rently involve immunohistochemistry, genetic manipulation,
or irradiation of mice, none of which reflect the native micro-
environments. Here, we report quantum dot immunoconstructs
that can be used for intravital imaging of single cells in un-
manipulated mice and multiplexed in vivo cytometric analysis
of rare cell populations.
Author contributions: H.-S.H., D.F., R.K.J., M.G.B., and D.G.D. designed research; H.-S.H.,
E.N., Y.H., W.S.K., J.D.M., J.B., Y.C., S.R., and J.C. performed research; H.-S.H. contributed
new reagents/analytic tools; H.-S.H., Y.H., W.S.K., J.D.M., and M.R.M. analyzed data; and
H.-S.H., M.G.B., and D.G.D. wrote the paper.
The authors declare no conflict of interest.
1To whom correspondence may be addressed. Email: jain@steele.mgh.harvard.edu or
mgb@mit.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1421632111/-/DCSupplemental.
1350–1355 | PNAS | February 3, 2015 | vol. 112 | no. 5 www.pnas.org/cgi/doi/10.1073/pnas.1421632111
incorporating imidazole and PEG) effectively passivate the QD
surface to achieve a high QY in aqueous solution (80–90%).
PIL-coated QDs show greatly enhanced stability in buffers and
blood sera, because the multidentate imidazole motifs of PILs
are chemically stable and exhibit a high affinity toward the Cd-
and Zn-rich QD surfaces (17). Norbornene, an uncharged
functional group, allows incorporation of a high number of deriv-
able functional groups while maintaining an overall neutral charge.
In contrast, conventional QDs displaying amine or carboxyl groups
suffer from nonspecific binding to cells and biomolecules because of
their surface charge. Implementing the advantages described above,
we synthesized QD conjugates [QD-norbornene–tetrazine-Ab con-
jugates (QDNB-TzAb)] by coupling NBPIL-coated QDs with tetra-
zine-modified Abs. In detail, QDNB-TzAbs were synthesized by
exchanging the native ligand of QDs with NBPILs and coupling
whole antibodies to QDs using tetrazine–norbornene cycloaddition
as shown in Fig. 1A. Tetrazine-modified antibodies were prepared
by reacting a tetrazine derivative with the lysine groups of antibodies
followed by immediate conjugation to the QDNB by mixing the
two components at room temperature. In this study, we synthesized
QDNB-TzAb conjugates with diverse combinations of QDs [CdSe/
CdZnS (QD612), CdSe/CdS (QD570), and InAs/CdZnS (QD800)]
and mAbs (anti-mouse CD31, CD45, c-Kit, and Sca-1 antibodies or
isotype-matched IgG).
Purification of free antibodies from QDNB-TzAb was essential
to achieve single-cell labeling in vivo. Without purification, sin-
gle-cell labeling results were inconsistent, and the labeling signal
intensities were extremely low. Inconsistencies and low signals
were caused by free antibodies left in the conjugate solution that
bind to targeting antigens on the cell surface and block the
binding of QD probes. The presence of free antibodies can
drastically interfere with the binding of QD probes in vivo due
to the following reasons. First, systemically injected QDs are
delivered to the target cells by extravasation from vessels and
diffusion throughout the interstitial space, and therefore, the
effective concentration of the probes around the target cells is
low. Second, the hydrodynamic diameter (HD) of free antibodies
(~12 nm) is slightly smaller than that of QD conjugates (15–17
nm), yielding faster extravasation and diffusion. A previous
method to conjugate EGF, a 6,045-Da protein with an HD of
2.7 nm, to QDs (16) utilizes dialysis filters to purify unconjugated
proteins. However, an Ab (a 150-kDa protein with an HD of
12 nm) has a similar size and charge as a QD, and therefore, it
is difficult to separate the two using commonly used size- or
charge-based purification methods. Instead, free antibodies
were successfully purified using gradient centrifugation. Sepa-
ration using this method is based on density, with denser QDs
and QD-Ab conjugate moving faster than free antibodies (SI
Appendix, Fig. S1).
The hydrodynamic size of nanomaterials influences their bi-
ological accessibility, local distribution, and clearance in a live
animal, and it can affect the motion of the targeted species (12,
13, 18, 19). To achieve sufficient transvascular permeability
and interstitial diffusion, QDNB-TzAb was made as compact as
possible by optimizing the incubation duration of QDNB with TzAb
and quenching unreacted tetrazine on the antibodies using
5-norbornene-2,2-dimethanol to prevent additional aggregation.
Polyimidazole ligands also contribute to the small HD of our QD
conjugates, because they directly bind to the QD surface (co-
ordinating ligands). In contrast, typical commercial water-soluble
QDs are prepared by encapsulating hydrophobic QDs with am-
phiphilic polymers and therefore, display higher HD. Dynamic
light scattering measurements show that both QD612
NB and
QD612
NB-TzAb were more compact than commercial Qdot 625
and Qdot 625-Ab (Life Technologies) (Fig. 1B and Table 1).
Charge has a major effect on the transport behavior of
nanoparticles in vivo and in vitro (20). A high surface charge,
either positive or negative, tends to trigger nonspecific uptake of
the particles by macrophages and results in more accumulation
of the particles in the liver than in the targeting region after systemic
administration. ζ-Potential measurements indicate that the surfaces
of our QDNB and QDNB-TzAb conjugates were moderately negative
(Fig. 1C and SI Appendix, Table S2).
Minimizing nonspecific protein adsorption on nanoparticles is
critical for single-cell targeting in vivo. Nonspecific protein ad-
sorption on particles not only hinders the application of the
particles to specific targeting but also, can trigger unwanted bi-
ological responses in vivo. The level of nonspecific interaction of
our QD probes with serum proteins was evaluated by incubating
QDNB emitting at 612 nm (QD612
NB) in FBS at 37 °C for 4 h and
monitoring the size change. The sizes of the QDs before and
after incubation were measured using fluorescence correlation
spectroscopy (SI Appendix, Fig. S2 and Table S5) and dynamic
light scattering. As shown in Table 1, the HD of QD612
NB did not
change after incubation in serum, indicating that QD612
NB does
not absorb serum proteins nonspecifically. In contrast, com-
mercial Qdot 625 (Life Technologies) showed a significant size
increase after serum incubation (Table 1).
In Vitro Specificity Study
The targeting specificity of QDNB-TzAb was first tested in vitro using
flow cytometry (Fig. 2). First, nonspecific binding of the QDNB and
the QDNB-TzAb on cells was tested by incubating QD570
NB, QD612
NB,
and QD570
NB-TzAb(IgG) with peripheral blood mononuclear
cells (PBMNCs), which were obtained from mice after lysis of
RBCs. Ab(IgG) stands for nonspecific control IgG, which should
show no binding ability. We did not detect any nonspecific ad-
sorption of the QDs and the QDNB-TzAb(IgG) on the PBMNCs
Fig. 1. QDNB-TzAb nanoconjugate synthesis and
characterization. (A) Conjugation of QDs to Abs. Ab
(IgG2a) is used to represent the Ab, and Lys residues
of Ab(IgG2a) are marked in red. This diagram is not
to scale. (B) Dynamic light scattering data of the QDs
and the QDNB-TzAb illustrate that QDNB/Ab conju-
gation does not yield noticeable aggregates and
that the size of QDNB-TzAb is compact. (C) ζ-Potential
measurements of the QDs and the QDNB-TzAb show
that the surface charge of QDNB and QDNB-TzAb is
moderately negative. (D) Gel filtration chromatog-
raphy (GFC) traces of QD612
NB before and after se-
rum incubation show that there is virtually no
nonspecific binding of QDNB to serum proteins.
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(SI Appendix, Fig. S8). We then incubated the PBMNCs with
QD612
NB-TzAb(CD45), a leukocyte marker. After incubation,
>75% of the PBMNCs showed high intensity of the QD612
emission (Fig. 2A, Center). We then tested whether QD612
NB-Tz
Ab(CD45) labeled all CD45+ cells by incubating PBMNCs
with QD612
NB-TzAb(CD45) and Ab(CD45)-PE/Cy7 (commercial
Ab) simultaneously. Fig. 2A, Right shows a good correlation
between the signals from Ab(CD45)-PE/Cy7 and QD612
NB-TzAb
(CD45), confirming efficient and specific immunostaining. The
specificity of QD612
NB-TzAb(Sca-1) and QD570
NB-TzAb(c-Kit),
which are used for single-cell imaging in vivo, was also tested
similarly with viable BMCs that were extracted from tibia and
femur bones of FVB mice. As expected, a good correlation be-
tween the signal from QDNB-TzAb and commercial antibodies
was observed (Fig. 2B). Of note, the expression level of antigens
varies significantly depending on both the type of antigen and the
cell type. Therefore, in some cases, antigen-positive cells are
clearly distinguishable from antigen-negative cells (Fig. 2A),
whereas in the other cases, the antigen expression level is rather
continuous (Fig. 2B).
In Vivo Specificity Study and Optimization of the Ratio
Between QDs and Abs
Before proceeding to single-cell labeling, we tested the in vivo
specificity of our QD-Ab conjugates by labeling blood vessels,
which are mesoscale objects. For the in vivo specificity test, QDs
or QD-Ab conjugates were administered through systemic in-
jection in the retro-orbital sinus to Tie2GFP/FVB transgenic
mice, which selectively express GFPs in endothelial cells, and the
blood vessels were imaged through a mammary fat pad window
using a multiphoton microscope. Nonspecific binding of QDNB
and QDNB -TzAb to cells and tissue was first tested by injecting
QD612
NB and QD612
NB-TzAb(IgG) and imaging vessels over 24 h.
Fig. 3 A and B and SI Appendix, Fig. S11 show that both of
QD612
NB and QD612
NB-TzAb(IgG) were cleared from the blood
circulation within 20 h with no evidence of nonspecific accu-
mulation. In contrast, we observed nonspecific accumulation of
commercial Qdot 625 and Qdot 625-Ab(IgG) in random spots
after the QDs were cleared from systemic circulation (Fig. 3 C
and D and SI Appendix, Fig. S12). In vivo specificity of QDNB-TzAb
was then studied by injecting QDNB-TzAb(CD31) systemically
and monitoring the labeling signals of endothelial cells over time.
Colocalization of the QD signal with the GFP signal confirmed
the specificity of the QD612
NB-TzAb(CD31) toward endothelial
cells (Fig. 3 E and F).
The performance of QDNB-TzAb samples with different ratios
between QDs and Abs was evaluated to achieve bright and stable
labeling signal in the vessel-labeling study. QD-Ab conjugates
containing a higher number of QDs are expected to yield
a brighter signal; however, a high number of QDs per Ab may
increase the chance of detachment of QDNB-TzAb from the la-
beled objects by perturbing the binding kinetics (lower affinity)
or triggering unexpected effects in vivo. To find the best ratio, we
synthesized QDNB-TzAb(CD31) with QD to Ab(CD31) ratios of
3:1, 1:1, and 1:3 and analyzed the intensity and pattern of the
labeling signals. As shown in Fig. 3 E and F and SI Appendix, Fig.
S13, QD612
NB-TzAb(CD31) with all three ratios specifically la-
beled the GFP+ vascular endothelium from 3 to 4 h up to 24 h
after systemic injection. After 24 h, the QD signal from the
vessels was still visible, but the observed pattern became more
punctate. The punctate staining pattern may be caused by either
endocytosis of the QD612
NB-TzAb(CD31) into endothelial cells
or detachment of the probe because of low affinity. The analyses
of the labeling intensities of vessels illustrate that the signal was
greater for QDNB-TzAb(CD31) having a higher ratio of QDs but
that the punctate pattern was also more dominant (SI Appendix,
Figs. S14 and S15). To achieve a balance between signal intensity
and signal stability, we chose the QDNB-TzAb with the QD:Ab
ratio of 1:1 for in vivo cytometry experiments.
Multiplexed Single-Cell Imaging in Vivo
We used our newly developed QDNB-TzAb to show the im-
aging of single cells from an endogenous rare population in
unmanipulated mice. As an example of rare cells, Sca1+c-Kit+
cells in the intact calvarial bone were imaged through a newly
established chronic calvarial window placed in C57/BL6 mice. In
mice, Sca1+c-Kit+ cells consist of multipotent progenitors (short-
and long-term hematopoietic stem cells) (21), which generate all
blood cells throughout the lifetime of the organism. Although
the function of hematopoietic stem and progenitor cells has
been well-characterized, locating the cell niche within the entire
bone marrow and studying cellular dynamics in their native
Table 1. HD of QDs or QD-Ab conjugates measured using
dynamic light scattering and fluorescence correlation
spectroscopy
QDs or QD conjugates
Inorganic diameter
(nm)
Average HD
(nm)
QD612
NB* 5.8 ± 0.5 12.5 ± 0.2
QD612
NB + FBS, 37 °C/4 h† 12.6 ± 0.2
QD612:Ab(CD31) = 1:1* 15.1 ± 0.3
QD612:Ab(CD31) = 3:1* 17.4 ± 0.6
Qdot 625 (Invitrogen)* 9.0 ± 1.0 20.0 ± 0.5
Qdot 625 + FBS, 37 °C/4 h† 33.4 ± 2.6
Qdot 625-Ab(CD31)* 20.5 ± 0.6
*Measured using dynamic light scattering.
†Measured using fluorescence correlation spectroscopy.
Fig. 2. In vitro specificity of QDNB-TzAb nanoconjugates. (A) Flow cytometric
analysis of PBMNCs immune-stained with QD nanoconjugates. Fluorophore
signal intensities for each cell, represented with red dots, are plotted on two
axes. (Left) Nonspecific binding test of QD570
NB-TzAb(IgG) to PBMNCs shows
that QD570
NB-TzAb(IgG) displays minimal nonspecific binding to cells. (Cen-
ter) After incubation of PBMNCs with QD612
NB-TzAb(CD45), >75% of PBMNCs
were labeled with QD612
NB-TzAb(CD45). (Right) After incubating PBMNCs
with QD612
NB-TzAb(CD45) and Ab(CD45)-PE/Cy7, strong correlation was ob-
served between the signals from QD612
NB-TzAb(CD45) and Ab(CD45)-PE/Cy7.
This result proves specificity of the QDNB-TzAb(CD45). (B) Flow cytometric
analysis of BMCs. Incubation of Lineage− BMCs with (Left) QD612
NB-TzAb(Sca-1)
and the Ab(Sca-1)-PE/Cy7 and (Right) QD570
NB-TzAb(c-Kit) and the Ab(c-Kit)-APC/
Cy7. Strong correlation between the signals from (Left) QD612
NB-TzAb(Sca-1) and
Ab(Sca-1)-PE/Cy7 and (Right) QD570
NB-TzAb(c-Kit) and Ab(c-Kit)-APC/Cy7 proves
the specificity of the QDNB-TzAb(Sca-1) and QDNB-TzAb(c-Kit).
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environments have been challenging because of the lack of
appropriate methodologies (22). Recently, a method combining
laser-scanning cytometry on tissue sections and confocal/multi-
photon microscopy on thick femoral bone marrow slices was
reported to study distribution patterns and the oxygenation sta-
tus of stem cell niches in the entire femoral bone marrow (23).
However, even this method used bone sectioning followed by ex
vivo imaging. Our single cell-labeling method enables single
Sca1+c-Kit+ cell imaging across the entire calvarial window in
unmanipulated live animals.
Intactness of a newly developed calvarial window was tested by
performing single-photon imaging of the bone marrow of ActbGFP/
C57BL/6 mice, which express GFP ubiquitously in all cells. As
shown in SI Appendix, Fig. S18, the bone marrow can be imaged from
day 0 to day 8 without any signs of inflammation or hemorrhage.
Unbiased statistical analyses from single-cell imaging requires
fluorescent probes that diffuse into the entire area of interest
and label all of the cells of interest. To verify whether QDNB-TzAb
diffuses throughout the whole bone marrow, we injected QDNB-TzAb
(CD45) into FVB mice through the tail vein, and we analyzed the
percentage of CD45+ BMCs that are labeled with our QD
immunoconstructs. The diffusion of our newly developed
QDNB-TzAb in vivo was then compared with that of commer-
cially available antibodies. The diffusion experiment was carried
out by (i) administering QDNB-TzAb(CD45) or commercial Ab
(CD45)-APC through the tail vein into mice, (ii) waiting 24 h to
allow the Ab-based probes to clear from vessels and interstitial
space, (iii) extracting BMCs from tibia and femur bones, (iv)
staining BMCs with Ab(CD45)-PE/Cy7 ex vivo, and (v) analyzing
the proportion of CD45+ BMCs that are labeled with QDNB-TzAb
(CD45) using flow cytometry (Fig. 4A). To target cells in vivo, the
Ab probes used in step i need to extravasate from vessels and
diffuse throughout the interstitial space. In contrast, Ab(CD45)-
PE/Cy7 used in step iv is directly incubated with BMCs and
therefore, labels all CD45+ BMCs. Fig. 4 B and C shows the flow
cytometry results on entire BMCs that have gone through the
procedures described above. The horizontal axis in Fig. 4 B and C
is the fluorescent intensity from QD612
NB-TzAb(CD45), and the
vertical axis in Fig. 4 B and C is the fluorescent intensity from Ab
(CD45)-PE/Cy7. CD45+ BMCs are colored green [based on the
Ab(CD45)-PE/Cy7 signal] and CD45− BMCs are colored red in
Fig. 4 B and C. As shown in Fig. 4 B and C, there were almost no
nonspecifically labeled cells, which would be Ab(CD45)-PE/Cy7–
negative and QD612
NB-TzAb(CD45)– or Ab(CD45)-allophycocyanin
(APC)–positive. In in Fig. 4 B, Right and C, Right, both CD45+
BMCs (green) and CD45− BMCs (red) are replotted against the
signal of the probes injected in vivo to clearly compare the
diffusion of QD612
NB-TzAb(CD45) (Fig. 4B) and Ab(CD45)-
APC (Fig. 4C). In Fig. 4B, most CD45+ BMCs (green) displayed
high fluorescent intensity in the QD612
NB-TzAb(CD45) channel,
which indicates that QD612
NB-TzAb(CD45) successfully labeled
most of CD45+ BMCs. In comparison, a bimodal distribution
(stained and nonstained) of the Ab(CD45)-APC signal intensities
was observed for CD45+ BMCs in Fig. 4C. This bimodal distri-
bution indicates that Ab(CD45)-APC did not label >30% of
CD45+ BMCs (Fig. 4C). Considering that the same amount of
Ab was injected in both experiments (100 μg), we can conclude
that QD612
NB-TzAb(CD45) is more efficient in labeling CD45+
BMCs than Ab(CD45)-APC. The higher population of observed
labeled cells using QD immunoconstructs than using commercial
antibodies may be explained by the higher optical absorption
coefficient of QDs. Because of their high absorption coefficient,
we expect that fewer QD conjugates are required for visualizing
single cells in vivo than commercial antibodies. Based on our
diffusion study, we claim that it is easier to detect cells that are
distant from vessels using our QD conjugates than commercial
antibodies. Differences in the deep tissue-labeling performance
between the QD conjugates and the dye-labeled antibodies are
even more extreme for multiphoton microscopy, because the
multiphoton action cross-section is at least two orders of mag-
nitude lower for organic dyes than for QDs (24).
Labeling of single cells from rare populations of hematopoi-
etic stem and progenitor cells was successfully achieved using
our QD immunoconstructs and multiphoton microscopy. Mul-
tiphoton microscopy was used to increase the imaging depth
and minimize cell damage and background signals. As imaging
probes, QD570
NB-TzAb(c-Kit) and QD612
NB-TzAb(Sca-1) (pop-
ular cell markers for hematopoietic stem and progenitor cells),
QD800
NB-TzAb(IgG) (nonspecific control), and Hoechst 33342
(a DNA-binding dye that labels most of the cells in the bone
marrow) were injected retro-orbitally in mice. Contrast-
enhanced angiography was used to detect the bone marrow
vessels, and second harmonic generation microscopy was used
to image the bone (3) (Fig. 5). Intravital multiphoton micros-
copy imaging was performed 24 h after the injection of the
QDNB-TzAb when unbound QDNB-TzAb was completely cleared
from the blood circulation and the bone marrow interstitial
space (25). Twenty-four hours after the injection, we observed
that ∼0.3% of cells within the bone marrow were labeled with
QDNB-TzAb(Sca-1) and QDNB-TzAb(c-Kit), but none were labeled
with QD800
NB-TzAb(IgG) (Fig. 5 and SI Appendix, Figs. S19–S21).
To confirm that we labeled all Sca1+c-Kit+ cells from BMCs, we
extracted BMCs from tibia and femur bones, stained them with
Ab(Sca-1)-PE/Cy7 and Ab(c-Kit)-APC/Cy7 ex vivo, and analyzed
Fig. 3. In vivo microscopy imaging of blood vas-
cular endothelial cells using QD-Ab conjugates. (A–
D) Imaging of nonspecific binding for (A) QD612
NB,
(B) QD612
NB-TzAb(IgG), (C) Qdot 625 (commercial),
and (D) Qdot625-Ab(IgG) (commercial). QD612
NB and
QD612
NB-TzAb(IgG) display virtually no nonspecific bind-
ing, whereas commercial Qdot 625 and Qdot625-Ab
(IgG) show significant nonspecific binding. (E and F)
Labeling of endothelial cells using the QD612
NB-TzAb
(CD31). Images taken at 4 and 24 h after the injection of
QD612
NB-TzAb(CD31) synthesized at QD:Ab ratios of (E)
3:1 and (F) 1:1 show that QD612
NB-TzAb(CD31) with
different ratios specifically labeled the GFP+ vascular
endothelium from 3 to 4 h up to 24 h after systemic
injection. Green and red signals represent fluorescence
from GFP+ vascular endothelium and QDs, respectively.
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the percentage of Sca1+, c-Kit+, and Sca1+c-Kit+ cells using flow
cytometry. As shown in SI Appendix, Fig. S22, populations of
c-Kit+, Sca1+, and Sca1+c-Kit+ cells were 2.779%, 2.132%, and
0.217%, respectively. The numbers closely match with the percentages
that are labeled with QDNB-TzAb(c-Kit), QDNB-TzAb(Sca-1),
and QDNB-TzAb(Sca-1)/QDNB-TzAb(c-Kit) in vivo, which were
∼3%, ∼1.7%, and ∼0.3%, respectively. The consistency between
in vitro and in vivo studies shows that our QD-Ab conjugates
specifically and accurately label cells in vivo. Note that these
population percentages are calculated from entire BMCs and
not from Lineage− BMCs. A detailed method for processing
raw images and identifying Sca1+c-Kit+ cells is described in SI
Appendix, Fig. 19. In addition, we were able to track single cells
in calvarial bone marrow for an extended period (>3 h). Movie
S1 shows a stably bound intravascular Sca1+c-Kit+ cell interact-
ing with a rolling WBC.
Lastly, we proved that the color or the composition of the QDs
does not affect the quality of the imaging by labeling Sca1+c-Kit+
cells using QDNB-TzAb with different combinations of QDs and
antibodies [QD800
NB-TzAb(c-Kit) and QD612
NB-TzAb(Sca-1)]. In
this experiment, bone marrow vessels were visualized using
endogenous GFP expression in endothelial cells in transgenic
Tie2GFP/FVB mice. SI Appendix, Fig. S23 shows successful la-
beling of Tie2+ Sca1+c-Kit+ and Tie2–Sca1+c-Kit+ cells, which
shows that diverse combinations of QDNB-TzAbs that emit from
the visible to the near-IR (NIR) can be used for multiplexed
phenotypic imaging in vivo.
Conclusions
For single endogenous cell labeling for microscopy imaging in
animals, fluorescent probes are administered systemically and
delivered to the target site through extravasation and diffusion.
Because the delivery determines the effective concentration of the
probes available for cell targeting, fluorophores for single-cell
tracking should meet highly strict criteria, such as compact size,
neutral charge, high brightness, high purity, and extremely low
Fig. 4. Analysis on in vivo diffusion of QD con-
jugates in bone marrow. (A) Experimental scheme.
B, Left and C, Left are 2D plots of BMCs against the
in vivo-stained probe signal (x axis; yellow box in A)
and ex vivo-stained probe signal (y axis; blue box in
A). CD45+ BMCs (green) were clearly distinguished
from CD45− BMCs (red) based on the Ab(CD45)-APC
signal. In B, Right and C, Right, both CD45+ BMCs
(green) and CD45− BMCs (red) are replotted against
the in vivo-stained probe to clearly compare the
diffusion of (B) QD612
NB-TzAb(CD45) with the diffu-
sion of (C) Ab(CD45)-APC. (B) Most of the CD45+
BMCs (green) were stained with QD612
NB-TzAb
(CD45). (C) Bimodal distribution of the Ab(CD45)-
APC signal intensities (stained and nonstained) was
observed for CD45+ BMCs, which indicates that
Ab(CD45)-APC did not label entire CD45+ BMCs.
Fig. 5. In vivo imaging of single endogenous Sca-1+c-Kit+ cells in the intact bone marrow using QDNB-TzAb. (A, Upper) A representative multiphoton mi-
croscopy image of a bone marrow cavity shown after removing the signal from the QD/Ab channels outside of the cells, which were segmented from Hoechst
33342 signal. Yellow cells (arrows) represent single Sca-1+c-Kit+ cells. Red and green cells represent Sca-1+ and c-Kit+ cells, respectively. An area containing an
Sca-1+c-Kit+ cell is magnified in Upper Right. Translucent red and gray areas represent vessels and the bone, respectively. Lower Left shows the unmodified
maximum intensity projection (∼10 μm in the z direction). Lower Right shows the maximum intensity projections of each channel individually. (B) Additional
images of bone marrow cavities containing Sca-1+c-Kit+ cells. Signals outside of the Hoechst 33342+ cells were discarded in these images, e.g., in A, Upper.
(Scale bars: 100 μm.)
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nonspecific interactions with biomolecules. These design rules are
much more stringent than those for commonly used in vitro
probes, where the probes are delivered to target cells by direct
incubation. For in vitro labeling, the lack of nonspecific binding to
serum/cell and the high purity of the probes are less critical owing
to intense signals from the high concentration of labeling probes.
The size of the probes is also not as critical as it is for in vivo
labeling, where diffusion in the dense in vivo environment must be
efficient to reach target cells.
Because of the strict requirements for single cell-labeling
probes in vivo, the development of such fluorophores requires
innovation and rigorous characterization. Here, we present QD-
Ab conjugates that (i) are easily and efficiently derivable with
targeting molecules or secondary reporters, (ii) display high
stability and maintain a high QY in complex in vivo environ-
ments, (iii) possess minimal nonspecific cell/serum binding, (iv)
exhibit long circulation half-life for enhanced delivery to target
sites, (v) are purified thoroughly from unbound targeting mole-
cules, because free-targeting molecules can block target sites and
yield a significantly decreased QD signal, (vi) have a compact
size for enhanced diffusion throughout dense in vivo environ-
ments, and (vii) have narrow emission for multiplexed imaging.
QDNB-TzAb conjugates bind specifically to cellular antigens both
in vitro and in vivo and perform better than the commercial
antibodies that we tested to label BMCs after systemic injection.
Our in vivo microscopy imaging results show the applicability of
QD-Ab conjugates for multiplexed in vivo cytrometric imaging of
endogenous rare cells in unmanipulated mice. Note that the QD
probes have several advantages over fluorescently labeled com-
mercial Abs. Commercial fluorescent Abs use organic dyes (e.g.,
Phycobilins and Cy7) as chromophores, and there are many
disadvantages associated with organic dyes, such as small mul-
tiphoton action cross-section, low photostability under intense
illumination, and asymmetric emission with red tails.
This technique offers new possibilities to study single-cell
interactions and responses and their microenvironments in live
animals. First, intense and stable fluorescent signal of QDs
allows long-term tracking of single cells in intact or diseased
tissues in vivo. Second, our technique can be applied to un-
manipulated animals as opposed to genetically modified,
immunodeficient, or preirradiated mice. This method may be
useful for the functional analysis of single endogenous cells in
their native environments, such as measuring the oxygen level,
glucose concentration, or local mechanical stress near the cell of
interest. Oxygen measurements in the bone marrow and the Ska-
1+c-Kit+ cell niche will be presented elsewhere. Third, the high
photostability of QDs allows for FRET studies in vivo for ex-
tended periods, which can be used to study the microenviron-
ments of target cells and cellular interactions. High photostability
is essential for FRET studies to maintain the QY of donors and
acceptors constant. Fourth, the technique described here can be
extended to single-cell imaging in deep tissues or highly scat-
tering environments by the use of NIR/IR QD-Ab conjugates.
QDs are especially useful for NIR/IR imaging, because NIR/IR
dyes display limited QY and orders of magnitude lower photo-
stability (26, 27). The challenges addressed and overcome in
this paper are not limited to QDs. Our work provides insights
for the rational design of any nanoconstructs for in vivo
applications.
Materials and Methods
Detailed methods on the following subjects are available in SI Appendix, SI
Materials and Methods: vendor information on the antibodies, mice models,
synthesis of QDs, QD ligands, tetrazine-modified Abs and QDNB-TzAb con-
jugates, fluorescence correlation spectroscopy, purification of QDNB-TzAb using
gradient centrifugation, bicinchoninic acid (BCA) assay for the measurement
of the ratios of QD to Ab in the QDNB-TzAb conjugates, flow cytometry (in-
cluding gating and compensation strategies), preparation of chronic bone
marrow window, intravital multiphoton imaging, physiological monitoring
of mice during intravital microscopy, and image analysis.
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